Anti-allergy Drugs

                   

Drug Companies Get Healthy, but at Whose Expense?

wired.com     19 hrs ago   4 related          

News from Portfolio.com Also on Portfolio Esquire, E-Ink: Future of Print? Hollywood's Sudden Cash Crunch Even Conservatives Hate Michael Savage Subscribe to Portfolio magazine Trevor Foltz was six months old last fall, fresh...                

comments

Balti-2 (Beta Agonist Lung injury TrIaI - 2)

warwick.ac.uk     21 hrs ago   1 related          

Aim of the Project The primary objective of the trial is to assess whether an intravenous infusion of salbutamol given at 15 µg (kg ideal body weight)-1 hour-1 for up to seven days reduces 28 day all-cause mortality in patients...                

comments

                   

Schering-Plough Stock Plunges 12% -- Vytorin Study Results Disappoint Wall Street

redorbit.com     yesterday   209 related          

Posted on: Tuesday, 22 July 2008, 21:00 CDT By Daniel Connolly Sales rose a slight 2 percent in the second quarter at the Memphis-based consumer products divisions of drug company Schering- And Schering-Plough stock sank Monday...                

comments

                   

Merck: A Future In Migraines

wsj.com     yesterday   38 related          

Annelena Lobb reports: Monday, disappointing results from a study of cholesterol drug Vytorin toppled shares of Merck and Schering-Plough. They fell 6.2% and 12%, respectively. Marketbeat spoke to Seamus Fernandez, analyst at...                

comments

                   

Codeine the silent addiction

independent.ie     yesterday          

The term 'heroin addiction' conjures up images of the down and out, malnourished and skeletal, banging up drugs in a backdrop of squalor with a dirty syringe full of god knows what; a tatty piece of cord-turned-tourniquet,...                

comments

                   
insidermedicine.com: Dimebon Improves Symptoms of Alzheimer's Over 12 Months (Interview with Rachelle Doody, MD, PhD) insidermedicine.com

Dimebon Improves Symptoms of Alzheimer's Over 12 Months (Interview with Rachelle Doody, MD, PhD)

insidermedicine.com     Jul 22, 2008   26 related          

The Russian antihistamine Dimebon improves mild-to-moderate symptoms of Alzheimer's disease over 12 months, according to a controlled trial published in this week's Dementia Special Edition of The Lancet. Here are some...                

comments

Merck 2Q profit rises on cost-cutting

ibtimes.com     Jul 21, 2008   6 related          

NEW YORK (AP) - Drug developer Merck says its second-quarter profit rose 5 percent as cost-cutting efforts offset a drop in sales of its asthma treatment Singulair and cholesterol drugs Zetia and Vytorin. Whitehouse Station,...                

comments

                   

Merck Reports Second-Quarter 2008 Financial Results (Business Wire)

yahoo.com     Jul 21, 2008   14 related          

Monday July 21, 4:37 pm ET -- Merck Updates Full-Year 2008 Product and Certain Other Guidance Elements; At This Time Not Providing 2008 Equity Income, 2008 EPS, and Long-Term Guidance WHITEHOUSE STATION, N.J.--(BUSINESS...                

comments

                   

ADHD Group Applauds Saskatchewan's decision to list long-acting medications

newswire.ca     Jul 21, 2008   20 related          

TORONTO, July 21 /CNW/ - The Centre for ADHD/ADD Advocacy, Canada (CADDAC) applauds the Saskatchewan Ministry of Health for its decision to provide access to long-acting ADHD medications with the listing of Concerta and...                

comments

                   

The Dangers of Mixing Medicines.

prettybynature.com     Jul 21, 2008   2 related          

Here is a little word of advice from me, take it as your Public Service Announcement. Really, when you notice on your prescription label that you should ask you doctor before taking other medicines with it, following that...                

comments

1 2 3 4 5 next »